Sign in
CD5 negative, Cyclin D1-positive diffuse large B-cell lymphoma (DLBCL) presenting as ruptured spleen
Journal article   Peer reviewed

CD5 negative, Cyclin D1-positive diffuse large B-cell lymphoma (DLBCL) presenting as ruptured spleen

Julie Teruya-Feldstein, Anuradha Gopalan and Craig H Moskowitz
Applied immunohistochemistry & molecular morphology, Vol.17(3), pp.255-258
2009-05
PMID: 18838919

Abstract

Antineoplastic Combined Chemotherapy Protocols CD5 Antigens - analysis Cyclin D1 - analysis Diagnosis, Differential Fatal Outcome Humans Lymphoma, Large B-Cell, Diffuse - diagnosis Lymphoma, Large B-Cell, Diffuse - drug therapy Male Middle Aged Rupture, Spontaneous - diagnosis Rupture, Spontaneous - drug therapy Splenic Rupture - diagnosis Tumor Suppressor Protein p53 - analysis Ubiquitin-Protein Ligases - analysis

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.130 Lymphomas
1.130.132 Lymphoma
Web Of Science research areas
Anatomy & Morphology
Medical Laboratory Technology
Pathology
ESI research areas
Biology & Biochemistry

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details